Total Payments
$7,956
2024 Payments
$222.85
Companies
32
Transactions
234
Medicare Patients
310
Medicare Billing
$27,387
Payment Breakdown by Category
Food & Beverage$7,951 (99.9%)
Education$5.26 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,951 | 233 | 99.9% |
| Education | $5.26 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,418 | 34 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $660.98 | 18 | $0 (2021) |
| Relypsa, Inc. | $605.39 | 6 | $0 (2019) |
| Novo Nordisk Inc | $555.63 | 7 | $0 (2022) |
| Lilly USA, LLC | $514.78 | 27 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $448.55 | 5 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $393.88 | 23 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $386.80 | 10 | $0 (2022) |
| Merck Sharp & Dohme LLC | $314.68 | 10 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $311.22 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.85 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($125.01) |
| 2023 | $112.63 | 1 | Lexicon Pharmaceuticals, Inc. ($112.63) |
| 2022 | $1,272 | 41 | Novo Nordisk Inc ($392.45) |
| 2021 | $1,624 | 57 | Amgen Inc. ($364.65) |
| 2020 | $886.03 | 42 | Teva Pharmaceuticals USA, Inc. ($201.38) |
| 2019 | $1,963 | 44 | Amgen Inc. ($613.14) |
| 2018 | $1,063 | 22 | AstraZeneca Pharmaceuticals LP ($169.64) |
| 2017 | $811.92 | 25 | Novartis Pharmaceuticals Corporation ($210.34) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $97.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Cardio-renal | ||||||
| 12/07/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $112.63 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 12/01/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $105.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/06/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Bone Health | ||||||
| 09/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Diabetes | ||||||
| 09/07/2022 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Neurology | ||||||
| 09/01/2022 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $16.19 | General |
| Category: Sleep | ||||||
| 08/29/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: Neuroscience | ||||||
| 08/26/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: Bone Health | ||||||
| 08/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $46.50 | General |
| 08/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $110.43 | General |
| Category: PRIMARY CARE | ||||||
| 07/27/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $14.71 | General |
| 07/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: DIABETES | ||||||
| 07/01/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Diabetes | ||||||
| 06/16/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Cardiology | ||||||
| 06/14/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: PRIMARY CARE | ||||||
| 05/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 89 | 121 | $14,330 | $8,314 |
| 2021 | 6 | 118 | 154 | $17,705 | $11,705 |
| 2020 | 5 | 103 | 114 | $12,925 | $7,368 |
Total Patients
310
Total Services
389
Medicare Billing
$27,387
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 34 | $5,610 | $3,593 | 64.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $3,000 | $2,150 | 71.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 30 | $3,450 | $2,091 | 60.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 25 | $1,250 | $315.87 | 25.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 17 | $1,020 | $164.20 | 16.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 37 | $6,105 | $4,217 | 69.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 45 | $5,175 | $3,405 | 65.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $3,400 | $2,470 | 72.7% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 15 | 15 | $1,050 | $996.45 | 94.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $595.00 | $315.01 | 52.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 20 | 23 | $1,380 | $301.76 | 21.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 30 | $4,950 | $2,635 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $2,400 | $1,532 | 63.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 29 | $3,335 | $1,517 | 45.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 21 | 21 | $1,470 | $1,281 | 87.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 22 | 22 | $770.00 | $403.26 | 52.4% |
About Dr. Maud Ward, M.D
Dr. Maud Ward, M.D is a Internal Medicine healthcare provider based in Cheshire, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609822709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maud Ward, M.D has received a total of $7,956 in payments from pharmaceutical and medical device companies, with $222.85 received in 2024. These payments were reported across 234 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,951).
As a Medicare-enrolled provider, Ward has provided services to 310 Medicare beneficiaries, totaling 389 services with total Medicare billing of $27,387. Data is available for 3 years (2020–2022), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cheshire, CT
- Active Since 05/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609822709
Products in Payments
- JARDIANCE (Drug) $627.77
- Veltassa (Drug) $605.39
- FARXIGA (Drug) $589.40
- EVENITY (Biological) $475.35
- ENTRESTO (Drug) $448.55
- Repatha (Biological) $402.85
- XARELTO (Drug) $359.32
- Prolia (Biological) $291.94
- AJOVY (Biological) $270.37
- Kerendia (Drug) $250.01
- Rybelsus (Drug) $250.00
- NURTEC ODT (Drug) $246.46
- Aimovig (Biological) $233.83
- UBRELVY (Drug) $177.16
- VRAYLAR (Drug) $143.78
- TRULICITY (Drug) $142.88
- Saxenda (Drug) $142.45
- RYBELSUS (Drug) $139.78
- Tymlos (Biological) $135.24
- Edarbyclor (Drug) $134.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cheshire
Dr. Christian Ward, M.d, M.D
Internal Medicine — Payments: $9,642
Internal Medicine $9,642
Dr. Josh Mosdale, M.d, M.D
Internal Medicine — Payments: $427.22
Internal Medicine $427.22
David Silver
Internal Medicine — Payments: $356.45
Internal Medicine $356.45
Dr. Stephen Ward, Md, MD
Internal Medicine — Payments: $187.65
Internal Medicine $187.65
Eileen O'regan, Md, MD
Internal Medicine — Payments: $138.20
Internal Medicine $138.20
David Stair, Md, MD
Internal Medicine — Payments: $125.00
Internal Medicine $125.00